Invention Publication
- Patent Title: Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
-
Application No.: US17986374Application Date: 2022-11-14
-
Publication No.: US20230151087A1Publication Date: 2023-05-18
- Inventor: Omoniyi Adedokun , Daphne Chan , Yang Chen , Philippe Szapary
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61P37/06
Abstract:
A method of treating Crohn's disease in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial intravenous dose and subsequent subcutaneous doses in order for the patient to respond to the antibody and meet one or more of the clinical endpoints.
Information query
